The House of Representatives last night approved 25 bills to combat the opioid crisis, including four supported by the AHA. The AHA-supported bills would provide resources for hospitals to develop protocols on discharging patients who have presented with an opioid overdose (H.R. 5176); establish a demonstration program to test alternative pain management protocols to limit opioid use in hospital emergency departments (H.R. 5197); direct the Centers for Medicare & Medicaid Services to evaluate coverage of abuse-deterrent opioids in Medicare plans (H.R. 5582); and include opioid use and pain management resources in the “Medicare & You” handbook (H.R. 5685). Next week, the House is expected to consider additional AHA-supported bills, including bills to improve information sharing among providers with regard to substance use disorder treatment by aligning 42 CFR Part 2 regulations with the Health Insurance Portability and Accountability Act; and allow states to receive federal matching funds for up to 30 days per year for services provided to adult Medicaid beneficiaries with an opioid use disorder in an Institution for Mental Disease. 
 

Related News Articles

Headline
The Food and Drug Administration Sept. 10 released draft guidance on non-opioid treatments for treating chronic pain and reducing prescription opioid misuse.…
Headline
The House Energy and Commerce Subcommittee on Health Sept. 10 advanced the Title VIII Nursing Workforce Reauthorization Act (H.R. 3593), AHA-supported…
Headline
The House Appropriations Committee Sept. 9 advanced the fiscal year 2026 appropriations bill for the Departments of Labor, Health and Human Services, Education…
Headline
A Health Affairs study published Sept. 2 found that less than 40% of Medicare beneficiaries with opioid use disorder received standard care in alignment with…
Headline
The AHA Sept. 4 expressed support for the Hospitals As Naloxone Distribution Sites Act (H.R. 5120), legislation that would require Medicare and Medicaid to…
Headline
The Food and Drug Administration July 31 announced that it is requiring safety label changes to all opioid pain medications to further emphasize and explain…